CD40LG and glioblastoma: In addition, a trend towards an elevated CD40L expression on the platelet surface was observed in GBM patients (GBM: median 1.4%, range from 0.9% to 3.1%/CON: median 1.2%, range from 0.4% to 1.6%/p = 0.10) (Figure 1D).